Lecture 8 Flashcards

1
Q

biases that exist in RCTs

A
  • selection bias

- measurement bias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

in a ____ study we are comparing two groups that differ in exposure but also differ in a number of other characteristics as well

A
  • cohort
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

difference in cohort studies versus RCTs

A
  • in RCTs we impose our own intervention
  • interventions are assigned randomly to participants
  • much stronger case for causation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

the benefit of randomizing in RCTs

A
  • confounding is basically eliminated.

- may be imbalances in factors strictly due to chance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

difference in analysis of RCTs versus cohort studies

A
  • analysis of RCTs is simpler than analysis of cohort studies because confounding can basically be ignored
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

problems arise when interpreting RCTs when the trial is ____

why

A
  • small
  • null hypothesis might not be rejected either because of low power or there being no difference in the groups
  • imbalance in intervention groups on important prognostic characteristics, by chance aline
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

type II error

A
  • fails to detect a difference when a difference does exist
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

should we wait for an RCT before using every medical intervention?

A
  • no.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

once as intervention becomes part of accepted clinical practice, even in the absence of evidence, it is perceived as ____ to perform a randomized clinical trial at that point

A
  • unethical
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

a recent example of a difference in findings between cohort studies and RCTs

A
  • effect of vitamin E on ischemic heart disease
  • cohorts said it reduced risk
  • RCTs said that it does not
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is the name for someone figuring out the randomization scheme and could subvert it in any way

ways to avoid this

A
  • allocation concealment
  • randomization done by people not involved in enrolling subjects
  • intervention assignment in a sealed envelope opened only after the patient has been enrolled in the study
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are crossovers

A
  • people assigned to one treatment but actually receive the comparison treatment

analyze these people based on treatment that they receive not on what they were assigned

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

intention to treat analysis

  • depends on
A
  • subjects analyzed according to the group to which they were randomized rather the treatment actually received
  • depends on the research question being asked
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

if participants are analyzed by the treatment they actually received, rather than what they were assigned to receive, one loses the advantages of the

A
  • the advantages of the randomization process are lost
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is the preferred method of analysis when attempting to determine if a given treatment produces a desired result

A
  • intention to treat
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what happens in intention to treat analyses if a large number of crossovers occur

A
  • underestimation of true treatment effect
17
Q

what is clinical equipoise

A
  • honest professional agreements exist about the preferred treatment of the condition in question
  • neither the experimental treatment nor the standard treatment should be considered inferior or potentially harmful to the patient.
  • RCT must produce results which are convincing enough to resolve the dispute over the preferred treatment
18
Q

what is the name for the extent to which the results of the student under review are applicable to a wider group of people

A
  • generalizability (external validity)